[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:mvi-score":3},{"name":4,"total":5,"recruiting":5,"trials":6},"MVI score",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06744647","Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation",[11],"Phase 2","RECRUITING","2026-08-03T02:49:28.132118Z","2026-05-05T02:47:14.272205Z"]